Fumio Imazeki spends much of his time researching Hepatitis, Immunology, Internal medicine, Virology and Hepatocellular carcinoma. His biological study deals with issues like Genetics, which deal with fields such as Physiology. Fumio Imazeki combines subjects such as Genetic marker and Allele frequency with his study of Immunology.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, HBsAg and Endocrinology. His studies in Hepatocellular carcinoma integrate themes in fields like Carcinoma, Pathology, Cirrhosis and Hepatitis C. Fumio Imazeki has researched Hepatitis B in several fields, including Chronic liver disease, Liver disease and Hepatitis B virus.
Fumio Imazeki focuses on Virology, Internal medicine, Gastroenterology, Immunology and Hepatitis C virus. Virology is frequently linked to Genotype in his study. His Chronic hepatitis research extends to the thematically linked field of Internal medicine.
Many of his research projects under Gastroenterology are closely connected to In patient with In patient, tying the diverse disciplines of science together. His study in Liver biopsy extends to Immunology with its themes. The concepts of his Hepatitis C virus study are interwoven with issues in Interferon, Hepatitis C and Adverse effect.
His main research concerns Internal medicine, Gastroenterology, Virology, Hepatitis C virus and Immunology. Fumio Imazeki interconnects Autoimmune hepatitis, Chronic hepatitis, Hepatitis C and Liver biopsy in the investigation of issues within Gastroenterology. The study incorporates disciplines such as Genotyping and Genotype in addition to Virology.
His Hepatitis C virus study combines topics in areas such as Interferon and Adverse effect. His Immunology study combines topics from a wide range of disciplines, such as Chronic liver disease and Anemia. His Hepatitis B virus research is multidisciplinary, relying on both Hepatitis B and Risk factor.
Fumio Imazeki mainly investigates Internal medicine, Virology, Immunology, Hepatitis B virus and Hepatitis C virus. His studies deal with areas such as Gastroenterology and Endocrinology as well as Internal medicine. His study in Gastroenterology is interdisciplinary in nature, drawing from both Transplantation, Etiology and Fulminant hepatitis.
He has included themes like Toll-like receptor, Retrospective cohort study, Genotype and Cell biology in his Virology study. His study in Immunology concentrates on Antibody and Interferon. Antigen is closely connected to Hepatitis B in his research, which is encompassed under the umbrella topic of Hepatitis B virus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan
Haruhiko Yoshida;Yasushi Shiratori;Mitsuhiko Moriyama;Yasuyuki Arakawa.
Annals of Internal Medicine (1999)
Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy
Yasushi Shiratori;Fumio Imazeki;Mitsuhiko Moriyama;Michitami Yano.
Annals of Internal Medicine (2000)
Incidence of hepatocellular carcinoma in chronic Hepatitis B and C: A prospective study of 251 patients
Susumu Takano;Osamu Yokosuka;Fumio Imazeki;Masami Tagawa.
Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease
Hajime Sumi;Osamu Yokosuka;Naohiko Seki;Makoto Arai.
Antiviral Therapy for Cirrhotic Hepatitis C: Association with Reduced Hepatocellular Carcinoma Development and Improved Survival
Yasushi Shiratori;Yoichi Ito;Osamu Yokosuka;Fumio Imazeki.
Annals of Internal Medicine (2005)
Resolution of acute hepatitis C after therapy with natural beta interferon.
M. Omata;O. Yokosuka;S. Takano;N. Kato.
The Lancet (1991)
Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease
Hiroshige Kojima;Osamu Yokosuka;Fumio Imazeki;Hiromitsu Saisho.
Precore mutations and core clustering mutations in chronic hepatitis B virus infection
Wan-Long Chuang;Masao Omata;Toshiki Ehata;Osamu Yokosuka.
High incidence of ADH2*1/ALDH2*1 genes among Japanese alcohol dependents and patients with alcoholic liver disease
F Tanaka;Y Shiratori;O Yokosuka;F Imazeki.
Bezafibrate treatment: a new medical approach for PBC patients?
Tatsuo Kanda;Osamu Yokosuka;Fumio Imazeki;Hiromitsu Saisho.
Journal of Gastroenterology (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: